Correlation Between Aerovate Therapeutics and Anebulo Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and Anebulo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and Anebulo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aerovate Therapeutics and Anebulo Pharmaceuticals, you can compare the effects of market volatilities on Aerovate Therapeutics and Anebulo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of Anebulo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and Anebulo Pharmaceuticals.
Diversification Opportunities for Aerovate Therapeutics and Anebulo Pharmaceuticals
-0.61 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Aerovate and Anebulo is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and Anebulo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Anebulo Pharmaceuticals and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with Anebulo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Anebulo Pharmaceuticals has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and Anebulo Pharmaceuticals go up and down completely randomly.
Pair Corralation between Aerovate Therapeutics and Anebulo Pharmaceuticals
Given the investment horizon of 90 days Aerovate Therapeutics is expected to under-perform the Anebulo Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Aerovate Therapeutics is 1.04 times less risky than Anebulo Pharmaceuticals. The stock trades about 0.0 of its potential returns per unit of risk. The Anebulo Pharmaceuticals is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 299.00 in Anebulo Pharmaceuticals on August 27, 2024 and sell it today you would lose (159.00) from holding Anebulo Pharmaceuticals or give up 53.18% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Aerovate Therapeutics vs. Anebulo Pharmaceuticals
Performance |
| Timeline |
| Aerovate Therapeutics |
| Anebulo Pharmaceuticals |
Aerovate Therapeutics and Anebulo Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aerovate Therapeutics and Anebulo Pharmaceuticals
The main advantage of trading using opposite Aerovate Therapeutics and Anebulo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, Anebulo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anebulo Pharmaceuticals will offset losses from the drop in Anebulo Pharmaceuticals' long position.| Aerovate Therapeutics vs. Eliem Therapeutics | Aerovate Therapeutics vs. HCW Biologics | Aerovate Therapeutics vs. Scpharmaceuticals | Aerovate Therapeutics vs. Milestone Pharmaceuticals |
| Anebulo Pharmaceuticals vs. Eliem Therapeutics | Anebulo Pharmaceuticals vs. HCW Biologics | Anebulo Pharmaceuticals vs. Scpharmaceuticals | Anebulo Pharmaceuticals vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Complementary Tools
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |